A Clinical Study to Determine the Safety and Effectiveness of Dentinal Hypersensitivity Treatment With Two Different Toothbrushes
Study Details
Study Description
Brief Summary
This study will determine the effects toothbrush type (power or manual) has on the safety and effectiveness of professional dentinal hypersensitivity treatment with a marketed oxalate-containing solution.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: oxalate liquid, SnF2 paste, manual toothbrush Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Manual toothbrush |
Device: Potassium Oxalate
Professionally applied liquid
Drug: Stannous fluoride paste
SnF2 Paste
Device: Manual toothbrush
Marketed manual toothbrush
|
Other: oxalate liquid, SnF2 paste, power toothbrush Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Power toothbrush |
Device: Potassium Oxalate
Professionally applied liquid
Drug: Stannous fluoride paste
SnF2 Paste
Device: Power toothbrush
Marketed power toothbrush
|
Outcome Measures
Primary Outcome Measures
- Change From Baseline Air Challenge [30 days]
The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows- 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subject responds to stimulus and requests discontinuation or moves form stimulus, 3: tooth/subject responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. The higher the Schiff score, the more sensitive the tooth. The mean change from Baseline was calculated for this measure.
Secondary Outcome Measures
- Change From Baseline Visual Analog Scale [30 days]
Visual Analog Scale (VAS) - subjects are asked to look at a VAS and designate the level of hypersensitivity they experienced as a result of the thermal and water challenges using a continuum scale of 0 = No tooth pain up to 100 = Worst tooth pain ever experienced.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
be at least 18 years of age;
-
provide written informed consent prior to participation and be given a signed copy of the informed consent form;
-
complete a photography consent agreement pertaining to the collection and use of non-identifying intraoral photographs;
-
be in good general health as determined by the Investigator/designee; and
-
have at least one tooth with a Schiff sensitivity score of at least 1 in response to the cool air challenge.
Exclusion Criteria:
-
self-reported pregnancy or nursing;
-
severe periodontal disease, as characterized by purulent exudate, generalized mobility, and/or severe recession;
-
active treatment of periodontitis;
-
any diseases or conditions that might interfere with the safe completion of the study; or
-
an inability to undergo any study procedures.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Chad J Anderson DMD Inc | Fresno | California | United States | 93730 |
Sponsors and Collaborators
- Procter and Gamble
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2015059
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Oxalate Liquid, SnF2 Paste, Manual Toothbrush | Oxalate Liquid, SnF2 Paste, Power Toothbrush |
---|---|---|
Arm/Group Description | Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Manual toothbrush Potassium Oxalate: Professionally applied liquid Stannous fluoride paste: SnF2 Paste Manual toothbrush: Marketed manual toothbrush | Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Power toothbrush Potassium Oxalate: Professionally applied liquid Stannous fluoride paste: SnF2 Paste Power toothbrush: Marketed power toothbrush |
Period Title: Overall Study | ||
STARTED | 12 | 12 |
COMPLETED | 11 | 12 |
NOT COMPLETED | 1 | 0 |
Baseline Characteristics
Arm/Group Title | Oxalate Liquid, SnF2 Paste, Manual Toothbrush | Oxalate Liquid, SnF2 Paste, Power Toothbrush | Total |
---|---|---|---|
Arm/Group Description | Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Manual toothbrush Potassium Oxalate: Professionally applied liquid Stannous fluoride paste: SnF2 Paste Manual toothbrush: Marketed manual toothbrush | Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Power toothbrush Potassium Oxalate: Professionally applied liquid Stannous fluoride paste: SnF2 Paste Power toothbrush: Marketed power toothbrush | Total of all reporting groups |
Overall Participants | 12 | 12 | 24 |
Age (Count of Participants) | |||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
12
100%
|
12
100%
|
24
100%
|
>=65 years |
0
0%
|
0
0%
|
0
0%
|
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
42.6
(14.74)
|
46.7
(9.63)
|
44.6
(12.36)
|
Sex: Female, Male (Count of Participants) | |||
Female |
10
83.3%
|
12
100%
|
22
91.7%
|
Male |
2
16.7%
|
0
0%
|
2
8.3%
|
Race/Ethnicity, Customized (Count of Participants) | |||
Caucasian |
7
58.3%
|
8
66.7%
|
15
62.5%
|
Black |
1
8.3%
|
0
0%
|
1
4.2%
|
Asian Oriental |
2
16.7%
|
1
8.3%
|
3
12.5%
|
Multi-Racial |
1
8.3%
|
1
8.3%
|
2
8.3%
|
Hispanic |
1
8.3%
|
2
16.7%
|
3
12.5%
|
Region of Enrollment (participants) [Number] | |||
United States |
12
100%
|
12
100%
|
24
100%
|
Outcome Measures
Title | Change From Baseline Air Challenge |
---|---|
Description | The Schiff Sensitivity Scale was assessed for each test tooth via an evaporative air challenge. The examiner recorded the Schiff Index score corresponding to the response to the air challenge. The Schiff Index Sensitivity scale is scored as follows- 0: tooth/subject did not respond to stimulus, 1: tooth/subject responds to stimulus, but does not request discontinuation of stimulus, 2: tooth/subject responds to stimulus and requests discontinuation or moves form stimulus, 3: tooth/subject responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. The higher the Schiff score, the more sensitive the tooth. The mean change from Baseline was calculated for this measure. |
Time Frame | 30 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Oxalate Liquid, SnF2 Paste, Manual Toothbrush | Oxalate Liquid, SnF2 Paste, Power Toothbrush |
---|---|---|
Arm/Group Description | Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Manual toothbrush Potassium Oxalate: Professionally applied liquid Stannous fluoride paste: SnF2 Paste Manual toothbrush: Marketed manual toothbrush | Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Power toothbrush Potassium Oxalate: Professionally applied liquid Stannous fluoride paste: SnF2 Paste Power toothbrush: Marketed power toothbrush |
Measure Participants | 11 | 12 |
Mean (Standard Deviation) [Units on a scale] |
-0.409
(0.701)
|
-0.917
(0.733)
|
Title | Change From Baseline Visual Analog Scale |
---|---|
Description | Visual Analog Scale (VAS) - subjects are asked to look at a VAS and designate the level of hypersensitivity they experienced as a result of the thermal and water challenges using a continuum scale of 0 = No tooth pain up to 100 = Worst tooth pain ever experienced. |
Time Frame | 30 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Oxalate Liquid, SnF2 Paste, Manual Toothbrush | Oxalate Liquid, SnF2 Paste, Power Toothbrush |
---|---|---|
Arm/Group Description | Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Manual toothbrush Potassium Oxalate: Professionally applied liquid Stannous fluoride paste: SnF2 Paste Manual toothbrush: Marketed manual toothbrush | Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Power toothbrush Potassium Oxalate: Professionally applied liquid Stannous fluoride paste: SnF2 Paste Power toothbrush: Marketed power toothbrush |
Measure Participants | 11 | 12 |
Mean (Standard Deviation) [Units on a scale] |
-11.000
(12.929)
|
-28.500
(21.075)
|
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Oxalate Liquid, SnF2 Paste, Manual Toothbrush | Oxalate Liquid, SnF2 Paste, Power Toothbrush | ||
Arm/Group Description | Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Manual toothbrush Potassium Oxalate: Professionally applied liquid Stannous fluoride paste: SnF2 Paste Manual toothbrush: Marketed manual toothbrush | Potassium oxalate liquid, professionally applied Stannous fluoride paste, self applied Power toothbrush Potassium Oxalate: Professionally applied liquid Stannous fluoride paste: SnF2 Paste Power toothbrush: Marketed power toothbrush | ||
All Cause Mortality |
||||
Oxalate Liquid, SnF2 Paste, Manual Toothbrush | Oxalate Liquid, SnF2 Paste, Power Toothbrush | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/12 (0%) | 0/12 (0%) | ||
Serious Adverse Events |
||||
Oxalate Liquid, SnF2 Paste, Manual Toothbrush | Oxalate Liquid, SnF2 Paste, Power Toothbrush | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/12 (0%) | 0/12 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Oxalate Liquid, SnF2 Paste, Manual Toothbrush | Oxalate Liquid, SnF2 Paste, Power Toothbrush | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/12 (0%) | 0/12 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Clinical Trial Manager |
---|---|
Organization | The Procter & Gamble Company |
Phone | 513-622-2489 |
peters.j.2@pg.com |
- 2015059